Written by Dr. Boaz Ganor and Dr. Miriam Halperin Wernli.

As the knowledge of manufacturing drugs and the processes behind it increase, the industry could be leaving itself wide open to a potential terrorist attack if proper security controls are not implemented.

First published in European Biopharmaceutical Review.

Click Here to view Article File